WASHINGTON (AP) — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated ...

In a busy reporting day for biotechs, Orthocell notes promising results of a follow-up study of its nerve repair device ...

FDA clears Gilead’s lenacapavir, a biannual HIV prevention shot shown to be nearly 100% effective in major trials.